These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 5494985)
1. [Pharmacodynamic examination of patients treated with gold preparations]. Sorensen SS Nord Med; 1970 Nov; 84(47):1508. PubMed ID: 5494985 [No Abstract] [Full Text] [Related]
2. [In vivo transport of gold in chrysotherapy of rheumatoid arthritis]. Yamanaka K; Yamada O; Yamazaki S Rinsho Byori; 1971 Jan; 19(1):68-73. PubMed ID: 5103833 [No Abstract] [Full Text] [Related]
3. Gold distribution in whole blood during chrysotherapy. Smith PM; Smith EM; Gottlieb NL J Lab Clin Med; 1973 Dec; 82(6):930-7. PubMed ID: 4202278 [No Abstract] [Full Text] [Related]
4. Pharmacokinetics of gold in rheumatoid arthritis. Gottlieb NL; Gray RG Agents Actions Suppl; 1981; 8():529-38. PubMed ID: 7008561 [No Abstract] [Full Text] [Related]
6. [Can complications with gold therapy be anticipated?]. Králík V Fysiatr Revmatol Vestn; 1968 Apr; 46(2):93-7. PubMed ID: 5690307 [No Abstract] [Full Text] [Related]
7. [Treatment of rheumatoid arthritis with gold preparations]. Beresten' TI Ter Arkh; 1979; 51(8):118-23. PubMed ID: 505295 [No Abstract] [Full Text] [Related]
8. Gold metabolism in patients with rheumatoid arthritis treated with gold compounds--reinvestigated. Mascarenhas BR; Granda JL; Freyberg RH Arthritis Rheum; 1972; 15(4):391-402. PubMed ID: 5046469 [No Abstract] [Full Text] [Related]
9. [Transport and effect of gold in vivo during gold therapy of chronic rheumatoid arthritis]. Yamanaka K; Yamada O; Minoda M; Yamazaki S Rinsho Byori; 1971 Aug; 19():Suppl:198-9. PubMed ID: 5167919 [No Abstract] [Full Text] [Related]
11. Tissue gold concentration in a rheumatoid arthritic receiving chrysotherapy. Gottlieb NL; Smith PM; Smith EM Arthritis Rheum; 1972; 15(1):16-22. PubMed ID: 5059639 [No Abstract] [Full Text] [Related]
13. [Treatment of rheumatoid arthritis with gold preparations under control of their concentration in the blood serum]. Beresten' TI; Trofimova TM Ter Arkh; 1980; 52(2):102-6. PubMed ID: 7376087 [No Abstract] [Full Text] [Related]
14. Plasma levels and urinary excretion of gold during routine treatment of rheumatoid arthritis. Krusius FE; Markkanen A; Peltola P Ann Rheum Dis; 1970 May; 29(3):232-5. PubMed ID: 5432590 [No Abstract] [Full Text] [Related]
15. [The detection of gold atoms in lymphocyte and erythrocyte chromatin following therapy with 2 different gold compounds in patients with chronic polyarthritis]. Bröll H; Tausch G; Teherani DK Wien Klin Wochenschr Suppl; 1984; 156():16. PubMed ID: 6442049 [No Abstract] [Full Text] [Related]
16. Experience and rationale of monitoring plasma levels of gold in rheumatoid arthritis. Lorber A Agents Actions Suppl; 1981; 8():539-73. PubMed ID: 6781239 [No Abstract] [Full Text] [Related]
17. [Significance of serum gold level determination during chrysotherapy]. Bahous I; Müller W Verh Dtsch Ges Rheumatol; 1976; 4():395-400. PubMed ID: 997815 [No Abstract] [Full Text] [Related]
18. [Gold excretion during standard chrysothiotherapy]. Králík V; Krejcí E; Král V Fysiatr Revmatol Vestn; 1972 Apr; 50(2):90-3. PubMed ID: 5062989 [No Abstract] [Full Text] [Related]
19. [Gold therapy of chronic polyarthritis]. Schattenkirchner M Schweiz Med Wochenschr; 1977 Aug; 107(33):1145-55. PubMed ID: 897651 [No Abstract] [Full Text] [Related]
20. Pharmacodynamics of 197Au and 195Au labeled aurothiomalate in blood. Correlation with course of rheumatoid arthritis, gold toxicity and gold excretion. Gottlieb NL; Smith PM; Smith EM Arthritis Rheum; 1974; 17(2):171-83. PubMed ID: 4814979 [No Abstract] [Full Text] [Related] [Next] [New Search]